The purpose of this study is to compare the effects of ultrasound cavitation and whole-body electromyostimulation (WB-EMS) on inflammatory markers in individuals with central obesity.

Sixty individuals with central obesity were recruited from private clinics. And underwent a screening process to determine their eligibility based on the inclusion and exclusion criteria. Eligible participants were informed about the study details, procedures, potential risks, and benefits before obtaining written informed consent

Inclusion Criteria:

• Adults aged 18-50 years.
• Individuals diagnosed with central obesity, defined as a waist circumference greater than 102 cm in men and 88 cm in women.
• Participants with a stable body weight for at least three months prior to the study.
• No engagement in regular physical activity or weight loss programs in the past six months.
• Willingness to adhere to study protocols and attend all scheduled sessions.

Exclusion Criteria:

• Individuals with chronic diseases other than obesity-related conditions, such as cardiovascular disease, diabetes, or severe hypertension.

  • Pregnant or lactating women.
  • Individuals with implanted electronic devices (e.g., pacemakers).
  • Participants with dermatological conditions or skin infections in the treatment area.
  • Individuals undergoing medication that may affect fat metabolism or inflammatory markers.